Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease.
Kim JW, Chung SW, Pyo JY, Chang SH, Kim MU, Park CH, Lee JS, Lee JS, Ha YJ, Kang EH, Lee YA, Park YB, Lee EY, Choe JY.
Kim JW, et al. Among authors: park yb, park ch.
Rheumatology (Oxford). 2023 Jul 5;62(7):2377-2385. doi: 10.1093/rheumatology/keac651.
Rheumatology (Oxford). 2023.
PMID: 36394143